Research Paper Volume 16, Issue 6 pp 5387—5411
Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer
Figure 5. Risk score for target gene signature and outcome in PCa patients. (A) Risk score of a 7-gene signature for predicting DFS. (B) Disease status and duration of cases. (C) Heatmap of the 7 gene expression in PCa patients. (D) Kaplan-Meier curve for DFS in the low- and high-risk groups. (E) ROC curve for the DFS prediction of risk score model. (F) Risk score of a 11-gene signature for predicting PFS. (G) Progression status and duration of cases. (H) Heatmap of the 11 gene expression in PCa patients. (I) Kaplan-Meier curve for PFS in the low- and high-risk groups. (J) ROC curve for the PFS prediction of risk score model.